0001062993-15-003496.txt : 20150622 0001062993-15-003496.hdr.sgml : 20150622 20150622145634 ACCESSION NUMBER: 0001062993-15-003496 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150422 FILED AS OF DATE: 20150622 DATE AS OF CHANGE: 20150622 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mattila Jyrki CENTRAL INDEX KEY: 0001297318 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 15944533 MAIL ADDRESS: STREET 1: AUXILIUM PHARMACEUTICALS, INC. STREET 2: 40 VALLEY STREAM PARKWAY CITY: MALVERN STATE: PA ZIP: 19355 4/A 1 form4a.xml AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4/A 2015-04-22 2015-04-23 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001297318 Mattila Jyrki C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 0 0 0 Stock Option (Right to Buy) 37.64 2015-04-22 4 A 0 15000 0 A 2025-04-22 Common Stock 15000 15000 D The purpose of this Form 4/A is solely to correct the exercise price of derivative securities granted to the reporting person and does not represent any acquisition or disposition of shares by the reporting person. The options were granted on April 22, 2015 and will vest in four equal annual installments beginning on the first anniversary of the grant date. /s/ Jyrki Mattila, by Carl A. Valenstein, attorney-in-fact 2015-06-22